Edition:
United States

Pulse Biosciences Inc (PLSE.OQ)

PLSE.OQ on NASDAQ Stock Exchange Capital Market

24.78USD
15 Dec 2017
Change (% chg)

$-0.13 (-0.52%)
Prev Close
$24.91
Open
$25.00
Day's High
$25.50
Day's Low
$24.34
Volume
64,515
Avg. Vol
80,849
52-wk High
$39.50
52-wk Low
$5.23

Chart for

About

Pulse Biosciences, Inc., formerly Electroblate, Inc., is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $404.94
Shares Outstanding(Mil.): 16.34
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

BRIEF-South Korea's SK Innovation plans to produce batteries in Hungary -media

* Plans to build new battery production unit in Komarom, northwest Hungary - Hungary's state news agency MTI cites environmental protection document published by the city hall of Komarom in northwest Hungary

Nov 29 2017

BRIEF-Pulse Biosciences Inc reports qtrly loss per share $‍0.52​

* Pulse Biosciences Inc - qtrly loss per share $‍0.52​ Source text for Eikon: (http://bit.ly/2AiM76K) Further company coverage:

Nov 07 2017

BRIEF-Pulse Biosciences announces transition of board of directors

* Pulse Biosciences announces transition of board of directors, extends appreciation to retiring members and welcomes new board members

Nov 03 2017

BRIEF-Pulse Biosciences announces $30 million private placement

* Pulse Biosciences - ‍entered into stock purchase agreement for purchase of 2 million shares of company's common stock at a price of $15.02 per share​ Source text for Eikon: Further company coverage:

Sep 25 2017

BRIEF-Pulse Biosciences announces withdrawal and planned resubmission of 510(k) application for the PulseTxTM System

* Pulse Biosciences Inc - "‍remain confident" in ability to obtain a 510(k) clearance for PulseTx System and more broadly for Nano-Pulse Stimulation​

Sep 11 2017

BRIEF-Pulse Biosciences qtrly loss per share $ 0.43

* Pulse Biosciences Inc - cash, cash equivalents, and investments totaled $15.4 million at June 30, 2017, compared to $16.4 million at December 31, 2016 Source text for Eikon: Further company coverage:

Jul 27 2017

BRIEF-Pulse Biosciences files for offering of 1.7 mln shares of common stock by selling stockholders

* Pulse biosciences inc files for offering of 1.7 million shares of common stock by selling stockholders - sec filing Source text for Eikon: Further company coverage:

Jun 30 2017

BRIEF-Pulse Biosciences files for mixed shelf of up to $150 mln

* Files for mixed shelf of up to $150 million - SEC filing Source text: (http://bit.ly/2svQ7MC) Further company coverage:

Jun 30 2017

Earnings vs. Estimates

No consensus analysis data available.